ANDA 85960, held by Watson Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 85960 (Chlorpromazine Hydrochloride), held by Watson Labs, was first approved by FDA on Nov 19, 1979, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 19, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride50MG ยท tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Apr 19, 1988 | Supplement 22Labeling | Approved | None posted |
| Nov 19, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters